---
title: TransNRank: Towards Accurate Neoantigen Ranking with Transformer
url: http://arxiv.org/abs/2608.01924v1
type: paper-summary
date: 2026-08-03
source_paper: 2026-08-03_08-57-43Z_TransNRank_TowardsAccurateNeoantigenRankingwithTra.md
generated_at: 2026-08-03 23:30
model: nvidia/nemotron-3-nano-4b
---

## Summary
The paper introduces TransNRank, a transformer‑based model for ranking neoantigens with improved recall. It achieves higher positive recall on benchmark datasets while reducing training time. The approach overcomes class imbalance and noisy data through a positive‑aware objective.

## Key Takeaways
- TransNRank uses self‑attention to capture both local and global peptide features, boosting the top‑20 recall from 46.9% to 53.1%.  
- A positive‑aware training objective gives more weight to scarce positive samples, mitigating class imbalance.  
- Removing irrelevant features does not hurt performance, indicating robustness of the model.

## Context
Transformer architectures have become dominant in sequence modeling tasks, offering superior handling of long‑range dependencies compared with linear or tree‑based methods. This work applies that capability to a high‑dimensional, imbalanced bioinformatics problem where prior models underperform.

## Implications
Accurate neoantigen prediction is crucial for personalized cancer immunotherapy, influencing drug development and patient selection. TransNRank’s efficiency and higher recall can accelerate clinical translation of immune‑targeted therapies.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2608.01924v1)
